Ming Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ming Yang has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Michael C. Roarke
Radiology
5 shared publicationsM.C. Roarke
Department of Radiology, Mayo Clinic, AZ, United States
4 shared publicationsAaron F. Yang
Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ
3 shared publicationsAllison C. Rosenthal
Department of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, Arizona
3 shared publications- Ba Duong Nguyen
Department of Radiology, Mayo Clinic, Phoenix, AZ 85054, USA
3 shared publications Reza Arsanjani
Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ
3 shared publications
Latest Publications
- 5 November 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (11)
Similar Tolerance of Glucagon‐Like PEPTIDE‐1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying
Introduction: Gastroparesis is considered a relative contraindication to glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) prescription. We examined outcomes of patients who underwent gastric scintigraphy to determine if emptying delays adversely affected tolerance of subsequent GLP‐1RA therapy. Methods: Patients with delayed (DGE) and normal (NGE) gastric emptying who were subsequently prescribed GLP‐1RAs were identified. GLP‐1RA prescribing profiles, gastrointestinal (GI) symptoms and treatments, and GLP‐1RA discontinuation were compared between patients with DGE versus NGE. Key Results: Eighty‐one patients were prescribed GLP‐1RAs after scintigraphy; 14/81 (17%) with DGE and 67/81 (83%) with NGE. Injectable semaglutide was most often prescribed and was taken at similar doses for DGE (11/14, 79%) and NGE (40/67, 60%) ( p = 0.23). GLP‐1RAs were initiated a median of 386 days (IQR 190, 474) after scintigraphy with DGE versus 315 days (IQR 157, 613) with NGE ( p = 0.86). GI symptoms developed in 5/14 (36%) with DGE versus 35/67 (52%) with NGE ( p = 0.38) and antiemetic ( p = 0.75) and prokinetic ( p = 1.00) use was similar between groups. GLP‐1RAs were discontinued in 45/81 (56%) patients including 14/45 (31%) for GI symptoms, which occurred similarly for DGE (3/8, 38%) and NGE (11/37, 30%) ( p = 0.70). Treatment durations were similar with DGE (318 days [IQR 223, 464]) versus NGE (193 days [IQR 83, 363]) ( p = 0.31). Conclusions and Inferences: GLP‐1RAs are taken at similar doses for similar durations, elicit similar symptoms, and are discontinued for similar reasons in patients with prior delayed versus normal gastric emptying. These observations do not support strictly avoiding GlP‐1RAs in gastroparesis and suggest they may be safely prescribed in many cases.
- 5 November 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (11)
Similar Tolerance of Glucagon‐Like PEPTIDE‐1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying
Introduction: Gastroparesis is considered a relative contraindication to glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) prescription. We examined outcomes of patients who underwent gastric scintigraphy to determine if emptying delays adversely affected tolerance of subsequent GLP‐1RA therapy. Methods: Patients with delayed (DGE) and normal (NGE) gastric emptying who were subsequently prescribed GLP‐1RAs were identified. GLP‐1RA prescribing profiles, gastrointestinal (GI) symptoms and treatments, and GLP‐1RA discontinuation were compared between patients with DGE versus NGE. Key Results: Eighty‐one patients were prescribed GLP‐1RAs after scintigraphy; 14/81 (17%) with DGE and 67/81 (83%) with NGE. Injectable semaglutide was most often prescribed and was taken at similar doses for DGE (11/14, 79%) and NGE (40/67, 60%) ( p = 0.23). GLP‐1RAs were initiated a median of 386 days (IQR 190, 474) after scintigraphy with DGE versus 315 days (IQR 157, 613) with NGE ( p = 0.86). GI symptoms developed in 5/14 (36%) with DGE versus 35/67 (52%) with NGE ( p = 0.38) and antiemetic ( p = 0.75) and prokinetic ( p = 1.00) use was similar between groups. GLP‐1RAs were discontinued in 45/81 (56%) patients including 14/45 (31%) for GI symptoms, which occurred similarly for DGE (3/8, 38%) and NGE (11/37, 30%) ( p = 0.70). Treatment durations were similar with DGE (318 days [IQR 223, 464]) versus NGE (193 days [IQR 83, 363]) ( p = 0.31). Conclusions and Inferences: GLP‐1RAs are taken at similar doses for similar durations, elicit similar symptoms, and are discontinued for similar reasons in patients with prior delayed versus normal gastric emptying. These observations do not support strictly avoiding GlP‐1RAs in gastroparesis and suggest they may be safely prescribed in many cases.
- Open Access
Molecular Regulation of Cardiomyocyte Cell Cycle and Regeneration
The regulation of the cardiomyocyte cell cycle is central to understanding heart regeneration. In adult mammals, cardiomyocytes withdraw from the cell cycle, limiting their ability to proliferate and repair heart tissue after injury. This process is controlled by intrinsic genetic programs and extrinsic signals, which together restrict the regenerative response in mature hearts. Understanding the mechanisms that regulate cardiomyocyte cell cycle activity is therefore critical for advancing cardiac regenerative medicine. In this review, we provide a comparative and integrated overview of cardiomyocyte cell cycle regulation in lower vertebrates and mammals, and discuss the major intrinsic factors that govern this process, including cyclin/CDK pathways, transcription factors and co-activators, oxygen and metabolic regulation, and epigenetic mechanisms. We also review the influence of hormones and growth factors, as well as the supportive roles of nonmyocyte populations in heart regeneration. By integrating findings across species, developmental stages, and regulatory levels, these findings highlight the complex regulatory network controlling cardiomyocyte proliferation and provide insight into potential therapeutic strategies for stimulating cardiac repair in the adult mammalian heart.
Open AccessMolecular Regulation of Cardiomyocyte Cell Cycle and Regeneration
The regulation of the cardiomyocyte cell cycle is central to understanding heart regeneration. In adult mammals, cardiomyocytes withdraw from the cell cycle, limiting their ability to proliferate and repair heart tissue after injury. This process is controlled by intrinsic genetic programs and extrinsic signals, which together restrict the regenerative response in mature hearts. Understanding the mechanisms that regulate cardiomyocyte cell cycle activity is therefore critical for advancing cardiac regenerative medicine. In this review, we provide a comparative and integrated overview of cardiomyocyte cell cycle regulation in lower vertebrates and mammals, and discuss the major intrinsic factors that govern this process, including cyclin/CDK pathways, transcription factors and co-activators, oxygen and metabolic regulation, and epigenetic mechanisms. We also review the influence of hormones and growth factors, as well as the supportive roles of nonmyocyte populations in heart regeneration. By integrating findings across species, developmental stages, and regulatory levels, these findings highlight the complex regulatory network controlling cardiomyocyte proliferation and provide insight into potential therapeutic strategies for stimulating cardiac repair in the adult mammalian heart.
- Open Access
- 18 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (8) , 838
Multi-Modality Imaging in Vasculitis
Systemic vasculitides are a rare and complex group of diseases that can affect multiple organ systems. Clinically, presentation may be vague and non-specific and as such, diagnosis and subsequent management are challenging. These entities are typically classified by the size of vessel involved, including large-vessel vasculitis (giant cell arteritis, Takayasu’s arteritis, and clinically isolated aortitis), medium-vessel vasculitis (including polyarteritis nodosa and Kawasaki disease), and small-vessel vasculitis (granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis). There are also other systemic vasculitides that do not fit in to these categories, such as Behcet’s disease, Cogan syndrome, and IgG4-related disease. Advances in medical imaging modalities have revolutionized the approach to diagnosis of these diseases. Specifically, color Doppler ultrasound, computed tomography and angiography, magnetic resonance imaging, positron emission tomography, or invasive catheterization as indicated have become fundamental in the work up of any patient with suspected systemic or localized vasculitis. This review presents the key diagnostic imaging modalities and their clinical utility in the evaluation of systemic vasculitis.
- 18 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (8) , 838
Open AccessMulti-Modality Imaging in Vasculitis
Systemic vasculitides are a rare and complex group of diseases that can affect multiple organ systems. Clinically, presentation may be vague and non-specific and as such, diagnosis and subsequent management are challenging. These entities are typically classified by the size of vessel involved, including large-vessel vasculitis (giant cell arteritis, Takayasu’s arteritis, and clinically isolated aortitis), medium-vessel vasculitis (including polyarteritis nodosa and Kawasaki disease), and small-vessel vasculitis (granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis). There are also other systemic vasculitides that do not fit in to these categories, such as Behcet’s disease, Cogan syndrome, and IgG4-related disease. Advances in medical imaging modalities have revolutionized the approach to diagnosis of these diseases. Specifically, color Doppler ultrasound, computed tomography and angiography, magnetic resonance imaging, positron emission tomography, or invasive catheterization as indicated have become fundamental in the work up of any patient with suspected systemic or localized vasculitis. This review presents the key diagnostic imaging modalities and their clinical utility in the evaluation of systemic vasculitis.
- 5 April 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (7) , e354-e356
68Ga-DOTATATE and 18F-FDG PET Imaging of a Rare Chordoid Meningioma With Intracranial Recurrence and Extracranial Metastases
Chordoid meningiomas, rare meningioma variants, are characterized by their histopathological features and clinical behavior resembling that of other chondroid/myxoid neoplasms. We present a case of pathology-proven chordoid meningioma imaged with both 68Ga-DOTATATE and 18F-FDG PET images during a complicated postoperative course with multiple episodes of local recurrence and, ultimately, extracranial metastasis. This case underscores the aggressive behavior of chordoid meningiomas while highlighting how molecular imaging plays an important role in clinical monitoring and guidance of management.
- 5 April 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (7) , e354-e356
68Ga-DOTATATE and 18F-FDG PET Imaging of a Rare Chordoid Meningioma With Intracranial Recurrence and Extracranial Metastases
Chordoid meningiomas, rare meningioma variants, are characterized by their histopathological features and clinical behavior resembling that of other chondroid/myxoid neoplasms. We present a case of pathology-proven chordoid meningioma imaged with both 68Ga-DOTATATE and 18F-FDG PET images during a complicated postoperative course with multiple episodes of local recurrence and, ultimately, extracranial metastasis. This case underscores the aggressive behavior of chordoid meningiomas while highlighting how molecular imaging plays an important role in clinical monitoring and guidance of management.
- Open Access
- 21 March 2024
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 11 (3) , 95
Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
Cardiac allograft vasculopathy (CAV) is a distinct form of coronary artery disease that represents a major cause of death beyond the first year after heart transplantation. The pathophysiology of CAV is still not completely elucidated; it involves progressive circumferential wall thickening of both the epicardial and intramyocardial coronary arteries. Coronary angiography is still considered the gold-standard test for the diagnosis of CAV, and intravascular ultrasound (IVUS) can detect early intimal thickening with improved sensitivity. However, these tests are invasive and are unable to visualize and evaluate coronary microcirculation. Increasing evidence for non-invasive surveillance techniques assessing both epicardial and microvascular components of CAV may help improve early detection. These include computed tomography coronary angiography (CTCA), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and vasodilator stress myocardial contrast echocardiography perfusion imaging. This review summarizes the current state of diagnostic modalities and their utility and prognostic value for CAV and also evaluates emerging tools that may improve the early detection of this complex disease.
- 21 March 2024
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 11 (3) , 95
Open AccessCardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
Cardiac allograft vasculopathy (CAV) is a distinct form of coronary artery disease that represents a major cause of death beyond the first year after heart transplantation. The pathophysiology of CAV is still not completely elucidated; it involves progressive circumferential wall thickening of both the epicardial and intramyocardial coronary arteries. Coronary angiography is still considered the gold-standard test for the diagnosis of CAV, and intravascular ultrasound (IVUS) can detect early intimal thickening with improved sensitivity. However, these tests are invasive and are unable to visualize and evaluate coronary microcirculation. Increasing evidence for non-invasive surveillance techniques assessing both epicardial and microvascular components of CAV may help improve early detection. These include computed tomography coronary angiography (CTCA), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and vasodilator stress myocardial contrast echocardiography perfusion imaging. This review summarizes the current state of diagnostic modalities and their utility and prognostic value for CAV and also evaluates emerging tools that may improve the early detection of this complex disease.
- Open Access
- 12 March 2024
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 52 (3) , 276-277
Unmasking of Agenesis of Right Pulmonary Artery with Unilateral Absence of Perfusion on Lung Scintigraphy
We present a rare finding on lung ventilation–perfusion (V/Q) scintigraphy for a woman with longstanding dyspnea. CT of the chest showed volume loss on the right side, which raised concern about possible bronchiolitis obliterans or Swyer–James–MacLeod syndrome; however, the right pulmonary artery could not be visualized. A subsequent V/Q scan showed absence of perfusion and decreased ventilation to the entire right lung, consistent with agenesis of the right pulmonary artery. The patient’s clinical course and imaging features mimicked Swyer–James–MacLeod syndrome, which usually presents with a matched perfusion defect in a single lung or lobe on V/Q scanning. This case highlights the importance of a multimodality imaging approach to achieve a diagnosis.
- 12 March 2024
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 52 (3) , 276-277
Open AccessUnmasking of Agenesis of Right Pulmonary Artery with Unilateral Absence of Perfusion on Lung Scintigraphy
We present a rare finding on lung ventilation–perfusion (V/Q) scintigraphy for a woman with longstanding dyspnea. CT of the chest showed volume loss on the right side, which raised concern about possible bronchiolitis obliterans or Swyer–James–MacLeod syndrome; however, the right pulmonary artery could not be visualized. A subsequent V/Q scan showed absence of perfusion and decreased ventilation to the entire right lung, consistent with agenesis of the right pulmonary artery. The patient’s clinical course and imaging features mimicked Swyer–James–MacLeod syndrome, which usually presents with a matched perfusion defect in a single lung or lobe on V/Q scanning. This case highlights the importance of a multimodality imaging approach to achieve a diagnosis.
- Open Access
- 18 October 2023
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 52 (2) , 177-178
Physiologic18F-FDG Uptake in Brown Adipose Tissue and Lactating Breast in a Patient with Hodgkin Lymphoma
We present the case of a young woman with Hodgkin lymphoma exhibiting physiologic 18F-FDG uptake in brown adipose tissue and lactating breast on consecutive 18F-FDG PET/CT scans. Both entities are common imaging interpretation pitfalls and should be recognized in oncologic 18F-FDG PET/CT practice. We review the imaging features and differential diagnosis of these 2 entities and discuss the radiation safety precautions during breastfeeding.
- 18 October 2023
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 52 (2) , 177-178
Open AccessPhysiologic18F-FDG Uptake in Brown Adipose Tissue and Lactating Breast in a Patient with Hodgkin Lymphoma
We present the case of a young woman with Hodgkin lymphoma exhibiting physiologic 18F-FDG uptake in brown adipose tissue and lactating breast on consecutive 18F-FDG PET/CT scans. Both entities are common imaging interpretation pitfalls and should be recognized in oncologic 18F-FDG PET/CT practice. We review the imaging features and differential diagnosis of these 2 entities and discuss the radiation safety precautions during breastfeeding.
- 17 November 2022
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 52 (5) , 340-345
Gastroenteropancreatic Neuroendocrine Tumor Metastasis to the Heart: Evaluation of Imaging Manifestations
- 17 November 2022
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 52 (5) , 340-345
Gastroenteropancreatic Neuroendocrine Tumor Metastasis to the Heart: Evaluation of Imaging Manifestations
- 30 August 2022
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 50 (4) , 348-352
The Complementary Role of68Ga-DOTATATE PET/CT in Diagnosis of Recurrent Meningioma
Introduction: Contrast-enhanced brain MRI is the choice of imaging modality in diagnosis and posttreatment evaluation, its role is limited in distinguishing recurrent lesion from postoperative change. 68Ga-DOTATATE is a somatostatin analog PET tracer which has high affinity to meningioma expressing somatostatin receptor. Methods and subjects: In this case series review, we described 8 patients with brain MRI suspected of recurrent meningioma who underwent focused 68Ga-DOTATATE PET/CT scan for radiation treatment planning. Results: The combined brain MRI and PET/CT allowed improved conspicuity of the lesions and aided radiation treatment planning. The time from the initial surgery to PET/CT scans varied widely ranging from 1 year to 12 years. Three patients had PET/CT shortly after the initial surgery (1-3 years) and underwent targeted radiation therapy. Subsequent imaging showed no evidence of recurrence. Four patients had prolonged time between the PET/CT and the initial surgery (7-12 years) which showed extensive tumor burden. All four patients expired shortly after the last PET/CT scan. Conclusion: 68Ga-DOTATATE PET shows promising complementary role in detection and treatment planning of recurrent meningioma.
- 30 August 2022
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 50 (4) , 348-352
The Complementary Role of68Ga-DOTATATE PET/CT in Diagnosis of Recurrent Meningioma
Introduction: Contrast-enhanced brain MRI is the choice of imaging modality in diagnosis and posttreatment evaluation, its role is limited in distinguishing recurrent lesion from postoperative change. 68Ga-DOTATATE is a somatostatin analog PET tracer which has high affinity to meningioma expressing somatostatin receptor. Methods and subjects: In this case series review, we described 8 patients with brain MRI suspected of recurrent meningioma who underwent focused 68Ga-DOTATATE PET/CT scan for radiation treatment planning. Results: The combined brain MRI and PET/CT allowed improved conspicuity of the lesions and aided radiation treatment planning. The time from the initial surgery to PET/CT scans varied widely ranging from 1 year to 12 years. Three patients had PET/CT shortly after the initial surgery (1-3 years) and underwent targeted radiation therapy. Subsequent imaging showed no evidence of recurrence. Four patients had prolonged time between the PET/CT and the initial surgery (7-12 years) which showed extensive tumor burden. All four patients expired shortly after the last PET/CT scan. Conclusion: 68Ga-DOTATATE PET shows promising complementary role in detection and treatment planning of recurrent meningioma.
- 10 June 2022
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (12) , e738-e739
Pulmonary Artery Angiomatoid Fibrous Histiocytoma Mimicking a Large Pulmonary Embolism
A 39-year-old man presented with progressive dyspnea and lower extremity edema. Doppler ultrasound demonstrated bilateral leg partially occluded venous thromboses. A V/Q scan revealed a mismatched perfusion defect involving the entire right middle and lower lobes. Subsequent CT pulmonary angiogram revealed a mass lesion occluding the right interlobar pulmonary artery. Endobronchial ultrasound–guided fine-needle aspiration of the mass was concerning for neoplasm. 18F-FDG PET/CT demonstrated marked hypermetabolism of the mass lesion. Patient underwent transmediastinal right pneumonectomy with histopathologic diagnosis of pulmonary artery angiomatoid fibrous histiocytoma, a rare etiology mimicking large pulmonary artery embolism.
- 10 June 2022
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (12) , e738-e739
Pulmonary Artery Angiomatoid Fibrous Histiocytoma Mimicking a Large Pulmonary Embolism
A 39-year-old man presented with progressive dyspnea and lower extremity edema. Doppler ultrasound demonstrated bilateral leg partially occluded venous thromboses. A V/Q scan revealed a mismatched perfusion defect involving the entire right middle and lower lobes. Subsequent CT pulmonary angiogram revealed a mass lesion occluding the right interlobar pulmonary artery. Endobronchial ultrasound–guided fine-needle aspiration of the mass was concerning for neoplasm. 18F-FDG PET/CT demonstrated marked hypermetabolism of the mass lesion. Patient underwent transmediastinal right pneumonectomy with histopathologic diagnosis of pulmonary artery angiomatoid fibrous histiocytoma, a rare etiology mimicking large pulmonary artery embolism.